MELBOURNE, Australia – 18 June 2018. Telix Pharmaceuticals today announced that a consortium of industry collaborators, including CSIRO, GE Health and ThermoFisher and Telix have been awarded an AUD $1.1m Science and Industry Endowment Fund (SIEF) grant to support the establishment of an advanced biopharmaceutical manufacturing footprint in Clayton, Victoria (Australia). The full media release can be accessed here.